Observational Study Agreement
Research payments
$878,219
Through program year 2021, $878,219 in research payments was reported against Observational Study Agreement, across 580 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $386,555 | 159 |
| 2020 | Research | $207,640 | 181 |
| 2019 | Research | $284,023 | 240 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Neehar Parikh Ann Arbor, MI Named on 59 payments
- Ahmed Kaseb Detroit, MI Named on 44 payments
- Beng Fuh Greenville, NC Named on 41 payments
- Roniel Cabrera Gainesville, FL Named on 34 payments
- Nikolaos Pyrsopoulos Newark, NJ Named on 33 payments
- Boris Naraev Gilbert, AZ Named on 25 payments
- Richard Kalman Philadelphia, PA Named on 23 payments
- Renuka Iyer Buffalo, NY Named on 23 payments
- Jyotsna Fuloria New Orleans, LA Named on 20 payments
- Reena Salgia Detroit, MI Named on 20 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.